vs

Side-by-side financial comparison of Arlo Technologies, Inc. (ARLO) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

Arlo Technologies, Inc. is the larger business by last-quarter revenue ($141.3M vs $75.5M, roughly 1.9× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 16.2%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 6.7%).

Arlo Technologies is an American company that makes wireless surveillance cameras. Prior to an initial public offering (IPO) on the New York Stock Exchange in August 2018, Arlo was a brand of such products by Netgear, which retained majority control after the IPO.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

ARLO vs PBYI — Head-to-Head

Bigger by revenue
ARLO
ARLO
1.9× larger
ARLO
$141.3M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+11.5% gap
PBYI
27.7%
16.2%
ARLO
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
6.7%
ARLO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARLO
ARLO
PBYI
PBYI
Revenue
$141.3M
$75.5M
Net Profit
$5.8M
Gross Margin
46.4%
69.3%
Operating Margin
3.3%
22.7%
Net Margin
4.1%
Revenue YoY
16.2%
27.7%
Net Profit YoY
218.6%
EPS (diluted)
$0.06
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARLO
ARLO
PBYI
PBYI
Q4 25
$141.3M
$75.5M
Q3 25
$139.5M
$54.5M
Q2 25
$129.4M
$52.4M
Q1 25
$119.1M
$46.0M
Q4 24
$121.6M
$59.1M
Q3 24
$137.7M
$80.5M
Q2 24
$127.4M
$47.1M
Q1 24
$124.2M
$43.8M
Net Profit
ARLO
ARLO
PBYI
PBYI
Q4 25
$5.8M
Q3 25
$6.9M
$8.8M
Q2 25
$3.1M
$5.9M
Q1 25
$-835.0K
$3.0M
Q4 24
$-4.9M
Q3 24
$-4.4M
$20.3M
Q2 24
$-11.6M
$-4.5M
Q1 24
$-9.6M
$-4.8M
Gross Margin
ARLO
ARLO
PBYI
PBYI
Q4 25
46.4%
69.3%
Q3 25
40.5%
77.7%
Q2 25
44.9%
76.5%
Q1 25
44.3%
77.1%
Q4 24
36.9%
76.4%
Q3 24
35.2%
63.9%
Q2 24
36.8%
77.4%
Q1 24
38.1%
75.5%
Operating Margin
ARLO
ARLO
PBYI
PBYI
Q4 25
3.3%
22.7%
Q3 25
0.6%
17.6%
Q2 25
1.5%
12.7%
Q1 25
-1.2%
8.7%
Q4 24
-5.0%
22.6%
Q3 24
-4.0%
27.4%
Q2 24
-10.0%
-4.6%
Q1 24
-8.5%
-5.3%
Net Margin
ARLO
ARLO
PBYI
PBYI
Q4 25
4.1%
Q3 25
4.9%
16.2%
Q2 25
2.4%
11.2%
Q1 25
-0.7%
6.5%
Q4 24
-4.0%
Q3 24
-3.2%
25.2%
Q2 24
-9.1%
-9.6%
Q1 24
-7.8%
-11.0%
EPS (diluted)
ARLO
ARLO
PBYI
PBYI
Q4 25
$0.06
$0.26
Q3 25
$0.06
$0.17
Q2 25
$0.03
$0.12
Q1 25
$-0.01
$0.06
Q4 24
$-0.05
$0.40
Q3 24
$-0.04
$0.41
Q2 24
$-0.12
$-0.09
Q1 24
$-0.10
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARLO
ARLO
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$146.4M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$127.8M
$130.3M
Total Assets
$310.5M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARLO
ARLO
PBYI
PBYI
Q4 25
$146.4M
$97.5M
Q3 25
$86.0M
$94.4M
Q2 25
$71.2M
$96.0M
Q1 25
$84.0M
$93.2M
Q4 24
$82.0M
$101.0M
Q3 24
$77.0M
$96.7M
Q2 24
$62.9M
$96.8M
Q1 24
$62.1M
$107.2M
Total Debt
ARLO
ARLO
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
ARLO
ARLO
PBYI
PBYI
Q4 25
$127.8M
$130.3M
Q3 25
$129.2M
$115.3M
Q2 25
$118.3M
$104.7M
Q1 25
$103.4M
$97.1M
Q4 24
$100.9M
$92.1M
Q3 24
$96.9M
$71.1M
Q2 24
$99.3M
$48.5M
Q1 24
$99.9M
$51.0M
Total Assets
ARLO
ARLO
PBYI
PBYI
Q4 25
$310.5M
$216.3M
Q3 25
$350.9M
$202.9M
Q2 25
$319.7M
$194.9M
Q1 25
$296.6M
$196.2M
Q4 24
$298.4M
$213.3M
Q3 24
$312.4M
$220.7M
Q2 24
$295.8M
$205.0M
Q1 24
$289.8M
$214.1M
Debt / Equity
ARLO
ARLO
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARLO
ARLO
PBYI
PBYI
Operating Cash FlowLast quarter
$19.8M
$14.4M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
3.43×
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARLO
ARLO
PBYI
PBYI
Q4 25
$19.8M
$14.4M
Q3 25
$19.2M
$9.7M
Q2 25
$8.8M
$14.1M
Q1 25
$30.9M
$3.6M
Q4 24
$6.7M
$15.6M
Q3 24
$18.4M
$11.0M
Q2 24
$6.5M
$1.0M
Q1 24
$19.8M
$11.2M
Free Cash Flow
ARLO
ARLO
PBYI
PBYI
Q4 25
$14.4M
Q3 25
$9.7M
Q2 25
$14.1M
Q1 25
$28.1M
$3.6M
Q4 24
$5.6M
$15.6M
Q3 24
$17.4M
$11.0M
Q2 24
$6.2M
$1.0M
Q1 24
$19.4M
FCF Margin
ARLO
ARLO
PBYI
PBYI
Q4 25
19.1%
Q3 25
17.7%
Q2 25
26.8%
Q1 25
23.6%
7.7%
Q4 24
4.6%
26.4%
Q3 24
12.6%
13.7%
Q2 24
4.8%
2.1%
Q1 24
15.7%
Capex Intensity
ARLO
ARLO
PBYI
PBYI
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
2.4%
0.1%
Q4 24
0.9%
0.0%
Q3 24
0.7%
0.0%
Q2 24
0.2%
0.0%
Q1 24
0.3%
0.0%
Cash Conversion
ARLO
ARLO
PBYI
PBYI
Q4 25
3.43×
Q3 25
2.79×
1.10×
Q2 25
2.83×
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARLO
ARLO

Subscriptions And Services$89.4M63%
Products$51.9M37%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons